Display Accessibility Tools

Accessibility Tools

Grayscale

Highlight Links

Change Contrast

Increase Text Size

Increase Letter Spacing

Readability Bar

Dyslexia Friendly Font

Increase Cursor Size

Work from MSU DD on KRAS-driven lung cancer

The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer

Article in Scientific Reports